Career history of Ronald J. Loggers
Former positions of Ronald J. Loggers
| Companies | Position | Start | End |
|---|---|---|---|
Multifund BV
 Multifund BV Investment ManagersFinance Multifund BV is an independent investment adviser headquartered in Reeuwijk, Netherlands and was founded in 2002. Multifund manages diversified assets. | Chief Executive Officer | 2005-11-30 | 2014-06-30 |
| Corporate Officer/Principal | 2005-11-30 | - | |
| Schreiner Luchtvaart Groep BV | Director/Board Member | - | 2014-04-27 |
ISA Pharmaceuticals BV
 ISA Pharmaceuticals BV Pharmaceuticals: MajorHealth Technology ISA Pharmaceuticals BV operates as a clinical-stage immunotherapy company. The firm develops novel therapeutic vaccines for cancer and infectious diseases. Its product portfolio builds on its proprietary SLP-technology (Synthetic Long Peptide) for the development of therapeutic vaccines. The firm holds the exclusive rights to LUMC's patent families for amongst others, the development of therapeutic vaccines. The company was founded by Cornelis J. M. Melief in 2004 and is headquartered in Leiden, the Netherlands. | Chief Executive Officer | 2013-05-31 | - |
| Chairman | 2013-05-31 | - |
Training of Ronald J. Loggers
| INSEAD | Masters Business Admin |
| Delft University of Technology | Graduate Degree |
Statistics
International
| Netherlands | 5 |
| France | 2 |
Operational
| Chief Executive Officer | 2 |
| Chairman | 1 |
| Corporate Officer/Principal | 1 |
Sectoral
| Consumer Services | 3 |
| Consumer Durables | 2 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 3 |
|---|---|
| Schreiner Luchtvaart Groep BV | Consumer Durables |
ISA Pharmaceuticals BV
ISA Pharmaceuticals BV Pharmaceuticals: MajorHealth Technology ISA Pharmaceuticals BV operates as a clinical-stage immunotherapy company. The firm develops novel therapeutic vaccines for cancer and infectious diseases. Its product portfolio builds on its proprietary SLP-technology (Synthetic Long Peptide) for the development of therapeutic vaccines. The firm holds the exclusive rights to LUMC's patent families for amongst others, the development of therapeutic vaccines. The company was founded by Cornelis J. M. Melief in 2004 and is headquartered in Leiden, the Netherlands. | Health Technology |
Multifund BV
Multifund BV Investment ManagersFinance Multifund BV is an independent investment adviser headquartered in Reeuwijk, Netherlands and was founded in 2002. Multifund manages diversified assets. | Finance |
- Stock Market
- Insiders
- Ronald J. Loggers
- Experience
